Literature DB >> 26213618

Molecular Epidemiology of Hepatocellular Carcinoma.

Yujin Hoshida1.   

Abstract

Entities:  

Year:  2012        PMID： 26213618      PMCID： PMC4512175          DOI： 10.1002/cld.117

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  38 in total

1.  dbHCCvar: a comprehensive database of human genetic variations in hepatocellular carcinoma.

Authors:  Xiao-Jia Yu; Fang Fang; Chun-Lei Tang; Lei Yao; Lu Yu; Long Yu
Journal:  Hum Mutat       Date:  2011-09-20       Impact factor: 4.878

Review 2.  Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges.

Authors:  Yujin Hoshida; Bryan C Fuchs; Kenneth K Tanabe
Journal:  Curr Cancer Drug Targets       Date:  2012-11-01       Impact factor: 3.428

3.  Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma.

Authors:  Meng Li; Hong Zhao; Xiaosong Zhang; Laura D Wood; Robert A Anders; Michael A Choti; Timothy M Pawlik; Hubert D Daniel; Rajesh Kannangai; G Johan A Offerhaus; Victor E Velculescu; Linfang Wang; Shibin Zhou; Bert Vogelstein; Ralph H Hruban; Nick Papadopoulos; Jianqiang Cai; Michael S Torbenson; Kenneth W Kinzler
Journal:  Nat Genet       Date:  2011-08-07       Impact factor: 38.330

4.  Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis.

Authors:  Bin Wang; Gang Huang; Dan Wang; Aijun Li; Zhipeng Xu; Ran Dong; Deqiang Zhang; Weiping Zhou
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

5.  A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients.

Authors:  Stephanie Roessler; Hu-Liang Jia; Anuradha Budhu; Marshonna Forgues; Qing-Hai Ye; Ju-Seog Lee; Snorri S Thorgeirsson; Zhongtang Sun; Zhao-You Tang; Lun-Xiu Qin; Xin Wei Wang
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

6.  Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype.

Authors:  Pal Kaposi-Novak; Ju-Seog Lee; Luis Gòmez-Quiroz; Cédric Coulouarn; Valentina M Factor; Snorri S Thorgeirsson
Journal:  J Clin Invest       Date:  2006-05-18       Impact factor: 14.808

Review 7.  Hepatocellular carcinoma.

Authors:  Alejandro Forner; Josep M Llovet; Jordi Bruix
Journal:  Lancet       Date:  2012-02-20       Impact factor: 79.321

8.  Gene expression in fixed tissues and outcome in hepatocellular carcinoma.

Authors:  Yujin Hoshida; Augusto Villanueva; Masahiro Kobayashi; Judit Peix; Derek Y Chiang; Amy Camargo; Supriya Gupta; Jamie Moore; Matthew J Wrobel; Jim Lerner; Michael Reich; Jennifer A Chan; Jonathan N Glickman; Kenji Ikeda; Masaji Hashimoto; Goro Watanabe; Maria G Daidone; Sasan Roayaie; Myron Schwartz; Swan Thung; Helga B Salvesen; Stacey Gabriel; Vincenzo Mazzaferro; Jordi Bruix; Scott L Friedman; Hiromitsu Kumada; Josep M Llovet; Todd R Golub
Journal:  N Engl J Med       Date:  2008-10-15       Impact factor: 91.245

9.  A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.

Authors:  Moira Marcolongo; Bradford Young; Francesca Dal Pero; Giovanna Fattovich; Laura Peraro; Maria Guido; Giada Sebastiani; Giorgio Palù; Alfredo Alberti
Journal:  Hepatology       Date:  2009-10       Impact factor: 17.425

10.  EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.

Authors:  Taro Yamashita; Marshonna Forgues; Wei Wang; Jin Woo Kim; Qinghai Ye; Huliang Jia; Anuradha Budhu; Krista A Zanetti; Yidong Chen; Lun-Xiu Qin; Zhao-You Tang; Xin Wei Wang
Journal:  Cancer Res       Date:  2008-03-01       Impact factor: 12.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.